| Product Code: ETC12772872 | Publication Date: Apr 2025 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Egypt Non-Small Cell Lung Cancer Market Overview |
3.1 Egypt Country Macro Economic Indicators |
3.2 Egypt Non-Small Cell Lung Cancer Market Revenues & Volume, 2021 & 2031F |
3.3 Egypt Non-Small Cell Lung Cancer Market - Industry Life Cycle |
3.4 Egypt Non-Small Cell Lung Cancer Market - Porter's Five Forces |
3.5 Egypt Non-Small Cell Lung Cancer Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Egypt Non-Small Cell Lung Cancer Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.7 Egypt Non-Small Cell Lung Cancer Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Egypt Non-Small Cell Lung Cancer Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Egypt Non-Small Cell Lung Cancer Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of non-small cell lung cancer in Egypt |
4.2.2 Advancements in medical technology and treatment options for non-small cell lung cancer |
4.2.3 Growing awareness and screening programs for early detection of the disease |
4.3 Market Restraints |
4.3.1 High cost of treatment and medications for non-small cell lung cancer |
4.3.2 Limited access to specialized healthcare facilities in certain regions of Egypt |
4.3.3 Stigma associated with lung cancer leading to late diagnosis and treatment |
5 Egypt Non-Small Cell Lung Cancer Market Trends |
6 Egypt Non-Small Cell Lung Cancer Market, By Types |
6.1 Egypt Non-Small Cell Lung Cancer Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Egypt Non-Small Cell Lung Cancer Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Egypt Non-Small Cell Lung Cancer Market Revenues & Volume, By Adenocarcinoma, 2021 - 2031F |
6.1.4 Egypt Non-Small Cell Lung Cancer Market Revenues & Volume, By Squamous Cell Carcinoma, 2021 - 2031F |
6.1.5 Egypt Non-Small Cell Lung Cancer Market Revenues & Volume, By Large Cell Carcinoma, 2021 - 2031F |
6.1.6 Egypt Non-Small Cell Lung Cancer Market Revenues & Volume, By Others, 2021 - 2031F |
6.2 Egypt Non-Small Cell Lung Cancer Market, By Treatment Type |
6.2.1 Overview and Analysis |
6.2.2 Egypt Non-Small Cell Lung Cancer Market Revenues & Volume, By Chemotherapy, 2021 - 2031F |
6.2.3 Egypt Non-Small Cell Lung Cancer Market Revenues & Volume, By Immunotherapy, 2021 - 2031F |
6.2.4 Egypt Non-Small Cell Lung Cancer Market Revenues & Volume, By Radiation Therapy, 2021 - 2031F |
6.2.5 Egypt Non-Small Cell Lung Cancer Market Revenues & Volume, By Targeted Therapy, 2021 - 2031F |
6.3 Egypt Non-Small Cell Lung Cancer Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Egypt Non-Small Cell Lung Cancer Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Egypt Non-Small Cell Lung Cancer Market Revenues & Volume, By Oncology Clinics, 2021 - 2031F |
6.3.4 Egypt Non-Small Cell Lung Cancer Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.3.5 Egypt Non-Small Cell Lung Cancer Market Revenues & Volume, By Specialty Centers, 2021 - 2031F |
6.4 Egypt Non-Small Cell Lung Cancer Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 Egypt Non-Small Cell Lung Cancer Market Revenues & Volume, By Cancer Treatment, 2021 - 2031F |
6.4.3 Egypt Non-Small Cell Lung Cancer Market Revenues & Volume, By Tumor Management, 2021 - 2031F |
6.4.4 Egypt Non-Small Cell Lung Cancer Market Revenues & Volume, By Clinical Trials, 2021 - 2031F |
6.4.5 Egypt Non-Small Cell Lung Cancer Market Revenues & Volume, By Personalized Medicine, 2021 - 2031F |
7 Egypt Non-Small Cell Lung Cancer Market Import-Export Trade Statistics |
7.1 Egypt Non-Small Cell Lung Cancer Market Export to Major Countries |
7.2 Egypt Non-Small Cell Lung Cancer Market Imports from Major Countries |
8 Egypt Non-Small Cell Lung Cancer Market Key Performance Indicators |
8.1 Average age of diagnosis of non-small cell lung cancer patients in Egypt |
8.2 Percentage of non-small cell lung cancer cases detected at advanced stages |
8.3 Rate of adoption of innovative treatment modalities for non-small cell lung cancer in Egypt |
9 Egypt Non-Small Cell Lung Cancer Market - Opportunity Assessment |
9.1 Egypt Non-Small Cell Lung Cancer Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Egypt Non-Small Cell Lung Cancer Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.3 Egypt Non-Small Cell Lung Cancer Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Egypt Non-Small Cell Lung Cancer Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Egypt Non-Small Cell Lung Cancer Market - Competitive Landscape |
10.1 Egypt Non-Small Cell Lung Cancer Market Revenue Share, By Companies, 2024 |
10.2 Egypt Non-Small Cell Lung Cancer Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here